- SG$194.61m
- SG$158.53m
- SG$658.42m
- 68
- 93
- 83
- 97
Annual income statement for Multi-Chem, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 456 | 480 | 604 | 617 | 658 |
| Cost of Revenue | |||||
| Gross Profit | 65.9 | 71.6 | 85.5 | 81.9 | 90 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 438 | 452 | 568 | 591 | 621 |
| Operating Profit | 17.9 | 28.2 | 35.7 | 25.8 | 37.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 14.6 | 25.8 | 36 | 25.6 | 36.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.75 | 19.6 | 27.3 | 20 | 27.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.84 | 17.8 | 25 | 20 | 27.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.84 | 17.8 | 25 | 20 | 27.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.076 | 0.179 | 0.271 | 0.221 | 0.299 |
| Dividends per Share | |||||
| Special Dividends per Share |